三鑫医疗（300453）7月30日主力资金净流入1781.91万元

Group 1 - The core viewpoint of the news is that Sanxin Medical (300453) has shown a positive performance in its stock price and financial results as of July 30, 2025, with a closing price of 8.85 yuan, up 1.49% [1] - The company reported a total operating revenue of 361 million yuan for Q1 2025, representing a year-on-year growth of 8.88%, and a net profit attributable to shareholders of 53.73 million yuan, which is a slight increase of 0.20% year-on-year [1] - The company has a current ratio of 1.619, a quick ratio of 1.229, and a debt-to-asset ratio of 33.83%, indicating a stable financial position [1] Group 2 - Sanxin Medical has made investments in 14 companies and participated in 776 bidding projects, showcasing its active engagement in the market [2] - The company holds 46 trademark registrations and 209 patents, reflecting its commitment to innovation and intellectual property [2] - Additionally, Sanxin Medical possesses 175 administrative licenses, indicating compliance with regulatory requirements [2]